Stephen DeFalco Net Worth

The estimated Net Worth of Stephen P De Falco is at least $861 Thousand dollars as of 25 May 2021. Mr. Falco owns over 109,231 units of Senseonics Inc stock worth over $460,805 and over the last 8 years he sold SENS stock worth over $218,462. In addition, he makes $181,625 as Independent Chairman of the Board at Senseonics Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. DeFalco SENS stock SEC Form 4 insiders trading

Stephen has made over 1 trades of the Senseonics Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently he sold 109,231 units of SENS stock worth $218,462 on 25 May 2021.

The largest trade he's ever made was selling 109,231 units of Senseonics Inc stock on 25 May 2021 worth over $218,462. On average, Stephen trades about 3,121 units every 0 days since 2016. As of 25 May 2021 he still owns at least 1,169,853 units of Senseonics Inc stock.

You can see the complete history of Mr. Falco stock trades at the bottom of the page.

Stephen DeFalco biography

Stephen P. DeFalco is Independent Chairman of the Board of the Company, since December 2015. Mr. DeFalco served as chairman of the Senseonics, Incorporated board of directors from 2010 to December 2015 and served as Senseonics, Incorporated's interim Chief Executive Officer from 2010 to 2011. In August 2019, Mr. DeFalco became the Chairman and Chief Executive Officer of Creation Technologies. From April 2018 to August 2019, Mr. DeFalco was a partner at Lindsay Goldberg & Co LLC. From 2011 until January 2018, Mr. DeFalco served as the Chief Executive Officer of Crane & Co, Inc., a global technology company, and also served on its board of directors. Previously, from 2005 to 2010, he served as the Chief Executive Officer and on the board of directors of Nordion Inc. (formerly MDS Inc.), a public life sciences company. Mr. DeFalco received his M.B.A. from the Massachusetts Institute of Technology—Sloan School of Management, his M.S.E.E. from Syracuse University and his B.S.M.E. from the Massachusetts Institute of Technology. Our Board of Directors believes that Mr. DeFalco's leadership, executive, managerial and business experience with life sciences companies qualifies him to serve as a director of our company.

What is the salary of Stephen DeFalco?

As the Independent Chairman of the Board of Senseonics Inc, the total compensation of Stephen DeFalco at Senseonics Inc is $181,625. There are 7 executives at Senseonics Inc getting paid more, with Timothy Goodnow having the highest compensation of $2,211,200.

How old is Stephen DeFalco?

Stephen DeFalco is 59, he's been the Independent Chairman of the Board of Senseonics Inc since 2015. There are 4 older and 11 younger executives at Senseonics Inc. The oldest executive at Senseonics Holdings Inc is Dr. Francine Ratner Kaufman M.D., 70, who is the Chief Medical Officer & Director.

What's Stephen DeFalco's mailing address?

Stephen's mailing address filed with the SEC is 20451 SENECA MEADOWS PARKWAY, , GERMANTOWN, MD, 20876-7005.

Insiders trading at Senseonics Inc

Over the last 9 years, insiders at Senseonics Inc have traded over $36,720,504 worth of Senseonics Inc stock and bought 30,963,337 units worth $56,759,340 . The most active insiders traders include Peter J Barris, M James Barrett, and Douglas A Roeder. On average, Senseonics Inc executives and independent directors trade stock every 45 days with the average trade being worth of $313,683. The most recent stock trade was executed by Sharon Larkin on 7 September 2023, trading 30,889 units of SENS stock currently worth $18,842.

What does Senseonics Inc do?

senseonics, inc. is a medical device startup company in germantown, maryland, usa (near washington, dc) developing transformative glucose monitoring products that are intended to enable people with diabetes to confidently live their lives with ease. utilizing breakthrough fluorescence sensing technology, the senseonics continuous glucose monitoring ("cgm"​) system is being designed to be the first fully implantable cgm that is highly accurate and stable throughout its long sensor life. the system consists of a very small sensor implanted under the skin, an external transmitter, and a mobile medical application, which allows for discreet, easy access to real-time glucose measurements without the need for a dedicated receiver.

Complete history of Mr. Falco stock trades at Senseonics Inc

Senseonics Inc executives and stock owners

Senseonics Inc executives and other stock owners filed with the SEC include:

• Timothy Goodnow,
  President, Chief Executive Officer, Director
• Francine Kaufman,
  Chief Medical Officer, Director
• Mukul Jain,
  Chief Operating Officer
• Dr. Timothy T. Goodnow,
  Pres, CEO & Director
• Dr. Francine Ratner Kaufman M.D.,
  Chief Medical Officer & Director
• Dr. Mukul Jain,
  Chief Operating Officer
• Mirasol Panlilio,
  Vice President and General Manager - Global Commercial Operations
• Stephen DeFalco,
  Independent Chairman of the Board
• Douglas Prince,
  Independent Director
• Douglas Roeder,
  Independent Director
• Peter Klein,
  Independent Director
• Edward Fiorentino,
  Independent Director
• Steven Edelman,
  Independent Director
• Robert Schumm,
  Director
• Anthony Raab,
  Director
• Nick Tressler,
  Chief Financial Officer, Treasurer, Secretary
• Kenneth L. Horton,
  Gen. Counsel & Corp. Devel. Advisor
• Nick B. Tressler M.B.A.,
  CFO, Sec. & Treasurer
• Sharon Larkin,
  
• Jon D Isaacson,
  Chief Financial Officer
• Michael J. Gill,
  Vice President of U.S. Sales
• M James Barrett,
  Director
• Lynne E Kelley,
  Chief Medical Officer
• Peter J Barris,
  10% owner
• R Don Elsey,
  CFO, Secretary and Treasurer
• Enterprise Associates 9 L P...,
  
• Enterprise Associates 10 L ...,
  
• Management Partners Viii, L...,
  
• Holdings Corp Phc,
  
• John Marotta,
  Director
• Kenneth L Horton,
  GC & Corp. Development Advisor
• Frederick T. Sullivan,
  Chief Financial Officer